MFN2 and metabolic dysfunction-associated steatotic liver disease: MFN2 is involved in various diseases such as pulmonary fibrosis (Chung, et al. 2019), nonalcoholic fatty liver disease (NAFLD) (Bórquez, et al. 2024), and myocardial lipotoxicity (Hu, et al. 2024).